Evidence map›Paper›PMID 33651405›Full record

ArticleElectrophoresis2021

Methionine oxidation of proteins analyzed by affinity capillary electrophoresis in presence of silver(I) and gold(III) ions.

Andrei Hutanu, Peter C Hauser, Bernd Moritz, Steffen Kiessig, Aurélie Noël, Jan O Stracke, Markus Wild, Maria A Schwarz

Open access · hybridAbstract read
In one paragraph

Article in Electrophoresis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Andrei HutanuPharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.ORCID 0000-0003-0174-5250
Peter C HauserDepartment of Chemistry, University of Basel, Basel, Switzerland.ORCID 0000-0002-7506-5971
Bernd MoritzPharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.ORCID 0000-0001-9116-1878
Steffen KiessigPharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.
Aurélie NoëlPharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.
Jan O StrackePharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.
Markus WildPharma Technical Development Europe (Biologics) Analytics, Basel, Switzerland.
Maria A SchwarzDepartment of Chemistry, University of Basel, Basel, Switzerland.
Roche (Switzerland) · CHUniversity of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative damage of biopharmaceuticals during manufacturing and storage is a key concern throughout pharmaceutical development. However, few simple and robust analytical methods are available for the determination of oxidation sites. Here, the potential of affinity capillary electrophoresis (ACE) in the separation of proteins with oxidized methionine (Met) residues is shown. Silver(I) and gold(I) ions have the attribute to selectively form complexes with thioethers over sulfoxides. The addition of these ions to the BGE leads to a selective complexation of Met residues and, thus, to a change of charge allowing separation of species according to the different oxidation states of Met. The mechanisms of these interactions are discussed and binding constants for peptides containing Met with silver(I) are calculated. Additionally, the proposed method can be used as an indicator of oxidative stress in large proteins. The presented technique is easily accessible, economical, and has rapid analysis times, adding new approaches to the analytical toolbox of Met sulfoxide detection.

Indexed as

GoldMethionineProteinsSilverCationsElectrophoresis, CapillaryOxidation-ReductionCationsGoldMethionineProteinsSilverAffinity capillary electrophoresisGoldMethionine sulfoxideMonoclonal antibodySilver

Identifiers

PMID33651405
PMCPMC9291207
OpenAlexW3135218945

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.